Literature DB >> 7691235

The cytoplasmic domain of P-selectin is phosphorylated on serine and threonine residues.

T Fujimoto1, R P McEver.   

Abstract

P-selectin is an adhesion receptor for leukocytes that is redistributed from secretory granule membranes to the surfaces of activated platelets and endothelial cells. The cytoplasmic domain of P-selectin contains two serines, two threonines, and one tyrosine that could potentially be phosphorylated. We found that P-selectin was phosphorylated in both platelets and endothelial cells and that phosphorylation rapidly increased after cell activation. Approximately 0.02, 0.05, and 0.08 mol of phosphate/mol of P-selectin were incorporated, respectively, into resting, thrombin-activated, and phorbol ester-activated platelets. Phosphorylation was completely inhibited by the protein kinase C inhibitors, staurosporine, H-7, and chelerythrine, and was enhanced by the phosphatase inhibitors, okadaic acid and calyculin-A. Phosphoamino acid analysis of 32P-labeled P-selectin showed that phosphorylation occurred predominantly on serine with lesser amounts on threonine. When expressed in transfected Chinese hamster ovary cells, P-selectin was also phosphorylated. Mutagenesis studies showed that Ser788 was the principal site of phosphorylation, with minor sites on the other serine and threonine residues of the cytoplasmic domain. Phosphorylation may regulate membrane trafficking or other functions of P-selectin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691235

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  P-Selectin: Basic Aspects.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

2.  "Stuck on sugars - how carbohydrates regulate cell adhesion, recognition, and signaling".

Authors:  Richard D Cummings
Journal:  Glycoconj J       Date:  2019-07-02       Impact factor: 2.916

3.  P-selectin induces the expression of tissue factor on monocytes.

Authors:  A Celi; G Pellegrini; R Lorenzet; A De Blasi; N Ready; B C Furie; B Furie
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

4.  Regulation of TLR4 signaling through the TRAF6/sNASP axis by reversible phosphorylation mediated by CK2 and PP4.

Authors:  Feng-Ming Yang; Hui-Ming Chang; Edward T H Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

5.  Determinants in the cytoplasmic domain of P-selectin required for sorting to secretory granules.

Authors:  P W Modderman; E A Beuling; L A Govers; J Calafat; H Janssen; A E Von dem Borne; A Sonnenberg
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

Review 6.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

7.  Endothelial cell regulation of leukocyte infiltration in inflammatory tissues.

Authors:  A Duperray; A Mantovani; M Introna; E Dejana
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

8.  Impact of elevated plasma serotonin on global gene expression of murine megakaryocytes.

Authors:  Charles P Mercado; Stephanie Byrum; Marjorie L Beggs; Endrit Ziu; Preeti Singh; Vinay R Raj; Randy S Haun; Fusun Kilic
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

9.  Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses.

Authors:  D W Hartwell; T N Mayadas; G Berger; P S Frenette; H Rayburn; R O Hynes; D D Wagner
Journal:  J Cell Biol       Date:  1998-11-16       Impact factor: 10.539

Review 10.  Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.

Authors:  Laura Amo; Estíbaliz Tamayo-Orbegozo; Natalia Maruri; Cristina Eguizabal; Olatz Zenarruzabeitia; Marta Riñón; Arantza Arrieta; Silvia Santos; Jorge Monge; Miguel Angel Vesga; Francisco Borrego; Susana Larrucea
Journal:  Front Oncol       Date:  2014-09-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.